BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26612225)

  • 21. [Adrenocortical carcinoma and its treatment].
    Tupikowski W; Bednarek-Tupikowska G; Florczak A
    Postepy Hig Med Dosw (Online); 2004 Feb; 58():27-36. PubMed ID: 15069374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of adrenocortical carcinoma.
    Ranvier GG; Inabnet WB
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional chemotherapy and emerging targeted therapy for advanced adrenocortical carcinoma.
    Xu YZ; Zhu Y
    Anticancer Agents Med Chem; 2013 Feb; 13(2):248-53. PubMed ID: 22934700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.
    Henning JEK; Deutschbein T; Altieri B; Steinhauer S; Kircher S; Sbiera S; Wild V; Schlötelburg W; Kroiss M; Perotti P; Rosenwald A; Berruti A; Fassnacht M; Ronchi CL
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4323-4332. PubMed ID: 29092062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive treatment of adrenocortical carcinoma.
    Terzolo M; Berruti A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):221-6. PubMed ID: 18438168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for advanced adrenal cancer: improvement from a molecular approach?
    Costa R; Wesolowski R; Raghavan D
    BJU Int; 2011 Nov; 108(10):1546-54. PubMed ID: 21883840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
    Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
    Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare adrenal tumors in children.
    Mihai R
    Semin Pediatr Surg; 2014 Apr; 23(2):71-5. PubMed ID: 24931351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane].
    Sasaki S
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):67-70. PubMed ID: 29362311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The challenge of developmental therapeutics for adrenocortical carcinoma.
    Costa R; Carneiro BA; Tavora F; Pai SG; Kaplan JB; Chae YK; Chandra S; Kopp PA; Giles FJ
    Oncotarget; 2016 Jul; 7(29):46734-46749. PubMed ID: 27102148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MECHANISMS OF ENDOCRINOLOGY: Cell cycle regulation in adrenocortical carcinoma.
    Pereira SS; Monteiro MP; Bourdeau I; Lacroix A; Pignatelli D
    Eur J Endocrinol; 2018 Aug; 179(2):R95-R110. PubMed ID: 29773584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocortical cancer treatment.
    Patalano A; Brancato V; Mantero F
    Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Adrenocortical Carcinoma.
    Jasim S; Habra MA
    Curr Oncol Rep; 2019 Feb; 21(3):20. PubMed ID: 30798468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic adrenocortical carcinoma of the ovary: An unexpected outcome.
    Salle L; Mas R; Teissier-Clément MP
    Ann Endocrinol (Paris); 2020 Oct; 81(5):516-518. PubMed ID: 32822651
    [No Abstract]   [Full Text] [Related]  

  • 37. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current Status and Future Targeted Therapy in Adrenocortical Cancer.
    Alyateem G; Nilubol N
    Front Endocrinol (Lausanne); 2021; 12():613248. PubMed ID: 33732213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of mitotane action by rosuvastatin: New insights for adrenocortical carcinoma management.
    Boulate G; Amazit L; Naman A; Seck A; Paci A; Lombes A; Pussard E; Baudin E; Lombes M; Hescot S
    Int J Oncol; 2019 Jun; 54(6):2149-2156. PubMed ID: 30942448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.